Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling - PubMed (original) (raw)
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
Steven J Van Laere et al. Breast Cancer Res Treat. 2006 Feb.
Free article
Abstract
Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer with high metastatic potential. Most patients have lymph node involvement at the time of diagnosis and 1/3 of the patients have distant metastases. In a previous study, we demonstrated that IBC is a distinct form of breast cancer in comparison with non-IBC. The aim of this study was to investigate the presence of the different molecular subtypes in our data set of 16 IBC and 18 non-IBC specimen. Therefore, we selected an 'intrinsic gene set' of 144 genes, present on our cDNA chips and common to the 'intrinsic gene set' described by Sorlie et al. [PNAS, 2003]. This set of genes was tested for performance in the Norway/Stanford data set by unsupervised hierarchical clustering. Expression centroids were then calculated for the core members of each of the five subclasses in the Norway/Stanford data set and used to classify our own specimens by calculating Spearman correlations between each sample and each centroid. We identified the same cell-of-origin subtypes in IBC as those already described in non-IBC. The classification was in good agreement with immunohistochemical data for estrogen receptor protein expression and cytokeratin 5/6 protein expression. Confirmation was done by an alternative unsupervised hierarchical clustering method. The robustness of this classification was assessed by an unsupervised hierarchical clustering with an alternative gene set of 141 genes related to the cell-of-origin subtypes, selected using a discriminating score and iterative random permutation testing. The contribution of the different cell-of-origin subtypes to the IBC phenotype was investigated by principal component analysis. Generally, the combined ErbB2-overexpressing and basal-like cluster was more expressed in IBC compared to non-IBC, whereas the combined luminal A, luminal B and normal-like cluster was more pronounced in non-IBC compared to IBC. The presence of the same molecular cell-of-origin subtypes in IBC as in non-IBC does not exclude the specific molecular nature of IBC, since gene lists that characterize IBC and non-IBC are entirely different from gene lists that define the different cell-of-origin subtypes, as evidenced by principal component analysis.
Similar articles
- Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Van den Eynden GG, et al. Breast Cancer Res Treat. 2006 Feb;95(3):219-28. doi: 10.1007/s10549-005-9002-1. Epub 2005 Oct 22. Breast Cancer Res Treat. 2006. PMID: 16244790 - Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Van Laere SJ, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56. doi: 10.1158/1078-0432.CCR-05-2800. Clin Cancer Res. 2006. PMID: 16740744 - Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Van Laere S, et al. Breast Cancer Res Treat. 2005 Oct;93(3):237-46. doi: 10.1007/s10549-005-5157-z. Breast Cancer Res Treat. 2005. PMID: 16172796 - Gene expression profiling of inflammatory breast cancer.
Bertucci F, Finetti P, Birnbaum D, Viens P. Bertucci F, et al. Cancer. 2010 Jun 1;116(11 Suppl):2783-93. doi: 10.1002/cncr.25165. Cancer. 2010. PMID: 20503410 Review. - The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Fadare O, Tavassoli FA. Fadare O, et al. Adv Anat Pathol. 2007 Sep;14(5):358-73. doi: 10.1097/PAP.0b013e31814b26fe. Adv Anat Pathol. 2007. PMID: 17717437 Review.
Cited by
- FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
Pintor S, Lopez A, Flores D, Lozoya B, Soti B, Pokhrel R, Negrete J, Persans MW, Gilkerson R, Gunn B, Keniry M. Pintor S, et al. FEBS Open Bio. 2023 Nov;13(11):2108-2123. doi: 10.1002/2211-5463.13696. Epub 2023 Aug 28. FEBS Open Bio. 2023. PMID: 37584250 Free PMC article. - Cyclin A2 and Ki-67 proliferation markers could be used to identify tumors with poor prognosis in African American women with breast cancer.
Beyene D, Naab T, Apprey V, Ricks-Santi L, Esnakula A, Qasim M, George M Jr, Minoza KG, Copeland RL Jr, Broome C, Kanaan Y. Beyene D, et al. J Cancer Biol. 2023;4(1):3-16. doi: 10.46439/cancerbiology.4.048. J Cancer Biol. 2023. PMID: 37273492 Free PMC article. - Characterization of Inflammatory Breast Cancer in Hispanic Women from Puerto Rico.
Quirindongo-Rivera C, Rullán-Varela V, Underill Z, Rivera M, Ortiz-Ortiz KJ, Martínez-Montemayor MM. Quirindongo-Rivera C, et al. J Cancer. 2022 Oct 24;13(14):3495-3502. doi: 10.7150/jca.77108. eCollection 2022. J Cancer. 2022. PMID: 36484009 Free PMC article. - Inflammatory Breast Cancer: The Secretome of HCMV+ Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers.
Mohamed HT, El-Sharkawy AA, El-Shinawi M, Schneider RJ, Mohamed MM. Mohamed HT, et al. Front Oncol. 2022 Jun 30;12:899622. doi: 10.3389/fonc.2022.899622. eCollection 2022. Front Oncol. 2022. PMID: 35847899 Free PMC article. - Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients.
Allouchery V, Perdrix A, Calbrix C, Berghian A, Lequesne J, Fontanilles M, Leheurteur M, Etancelin P, Sarafan-Vasseur N, Di Fiore F, Clatot F. Allouchery V, et al. Sci Rep. 2021 Dec 15;11(1):24041. doi: 10.1038/s41598-021-02643-y. Sci Rep. 2021. PMID: 34911971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous